Edition:
United States

ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

5.43USD
12 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$5.43
Open
$5.47
Day's High
$5.82
Day's Low
$5.42
Volume
552,616
Avg. Vol
546,501
52-wk High
$13.41
52-wk Low
$5.11

Chart for

About

ImmunoGen, Inc. is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its antibody-drug conjugate (ADC) technology. An ADC with the Company's technology comprises an antibody that binds to a target found on tumor cells conjugated to one of its anti-cancer agents as a payload to kill the tumor... (more)

Overall

Beta: 2.22
Market Cap(Mil.): $768.71
Shares Outstanding(Mil.): 112.22
Dividend: --
Yield (%): --

Financials

  IMGN.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.21 -- --
ROI: -63.15 9.01 14.96
ROE: -- 10.15 16.52

Earnings vs. Estimates